Sponsors (14)
The bill lets states provide stronger local protections and greater product transparency for consumers, but it creates regulatory variation that raises compliance costs, legal complexity, and the risk of reduced product availability or higher prices for some Americans.
Residents in states and localities can have stronger protections because state and local governments may restrict or ban specific cosmetic ingredients to protect public health.
States may keep existing ingredient-reporting rules, preserving local transparency requirements that consumers, advocacy groups, and local regulators rely on.
States can require greater disclosure or manufacturing transparency than federal law, potentially giving consumers more information about the products they buy.
Cosmetic manufacturers — especially small firms — may face higher compliance costs from having to meet different state rules, which can raise prices for consumers.
Differing state standards could complicate interstate commerce and enforcement, creating legal uncertainty and administrative burdens for manufacturers and federal/state regulators (e.g., FDA).
Some consumers in states with stricter rules could face reduced product availability if manufacturers withdraw products rather than comply with multiple state-specific requirements.
Based on analysis of 2 sections of legislative text.
Clarifies that federal cosmetics law does not displace state or local limits, reporting, or stronger transparency requirements unless federal law expressly says so.
Official title: To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes.
Introduced July 16, 2025 by Janice D. Schakowsky · Last progress July 16, 2025
Clarifies that federal updates to cosmetics law do not broadly preempt state or local rules: states and their subdivisions can continue to ban or limit cosmetic ingredients, keep ingredient-reporting requirements already in place, and adopt or maintain stronger transparency, disclosure, or consumer-protection rules than the federal law. The change amends the Federal Food, Drug, and Cosmetic Act to make the non-preemption and state-authority exceptions explicit and preserves existing state authority except where the federal law expressly says otherwise.